Fizzer Pharmaceutical paid $80 million on January 2, 2016, for 2 million shares of Came Cosmetics common stock. The investment represents a 25% interest in the not assets of Came and gave Fizzer the ability to exercise significant influence over Crane's operations. Fizzer received dividends of $3 per share on December 21, 2016. and Came reported net income of $52 million for the year ended December 31, 2016. The fair value of came's common stock at December 31, 2016, was $30.5 per share. The book value of came's net assets was $206 million. The fair value of came's depreciable assets exceeded their book value by $32 million. These assets had an average remaining useful life of eight years. The remainder of the excess of the cost of the investment over the book value of net assets purchased was attributable to goodwill. Complete the table below and prepare the appropriate journal entries related to the investment during 2016. (if no entry is required for a transaction/event, select "No journal entry required" in the first account field. Enter your answers In millions rounded to two decimal places, (i.e.. 10, 000, 000 should be entered as 10).)